Invention Grant
- Patent Title: Heterocyclic compounds as inhibitors of Vanin-1 enzyme
-
Application No.: US15574625Application Date: 2016-05-16
-
Publication No.: US10308615B2Publication Date: 2019-06-04
- Inventor: Agustin Casimiro-Garcia , Jeffrey Scott Condon , Andrew Christopher Flick , Ariamala Gopalsamy , Steven J. Kirincich , John Paul Mathias , Joseph Walter Strobach , Jason Shaoyun Xiang , Li Huang Xing , Xiaolun Wang
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent James T. Wasicak
- International Application: PCT/IB2016/052825 WO 20160516
- International Announcement: WO2016/193844 WO 20161208
- Main IPC: C07D239/42
- IPC: C07D239/42 ; C07D401/12 ; C07D403/12 ; A61K31/505 ; C07D239/28 ; C07D241/14 ; A61P1/00 ; A61P1/04 ; A61P35/00 ; C07D405/10
Abstract:
Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Public/Granted literature
- US20180148420A1 NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME Public/Granted day:2018-05-31
Information query
